• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过同时定量癌胚抗原(CEA)和神经元特异性烯醇化酶(NSE)的胸腔积液水平来改善肺癌患者胸腔积液病因的诊断。

Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.

作者信息

Menard O, Dousset B, Jacob C, Martinet Y

机构信息

Service de Pneumologie, Hôpital de Brabois, Vandoeuvre-les-Nancy, France.

出版信息

Eur J Cancer. 1993;29A(13):1806-9. doi: 10.1016/0959-8049(93)90525-k.

DOI:10.1016/0959-8049(93)90525-k
PMID:8260229
Abstract

Carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) level determinations were carried out by radioimmunoassay in pleural fluid and plasma samples obtained from 24 patients with malignant pleural effusions and 18 patients with non-malignant pleural effusions, and compared to cytological and pathological results. Using a pathological cut-off level of 25 ng/ml for CEA and 8 ng/ml for NSE, we demonstrated that, in the diagnosis of the malignant nature of pleural effusions, the simultaneous quantification of CEA and NSE in pleural fluid possesses better discriminative values than the simultaneous quantification of both markers in plasma or the separate quantification of each marker, in pleural fluid and in plasma.

摘要

采用放射免疫分析法对24例恶性胸腔积液患者和18例非恶性胸腔积液患者的胸水及血浆样本进行癌胚抗原(CEA)和神经元特异性烯醇化酶(NSE)水平测定,并与细胞学和病理结果进行比较。以CEA病理临界值25 ng/ml和NSE病理临界值8 ng/ml为标准,我们发现,在诊断胸腔积液的恶性性质时,胸水同时定量检测CEA和NSE比血浆同时定量检测这两种标志物或胸水及血浆分别定量检测单一标志物具有更好的鉴别价值。

相似文献

1
Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.通过同时定量癌胚抗原(CEA)和神经元特异性烯醇化酶(NSE)的胸腔积液水平来改善肺癌患者胸腔积液病因的诊断。
Eur J Cancer. 1993;29A(13):1806-9. doi: 10.1016/0959-8049(93)90525-k.
2
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.CYFRA 21-1、癌胚抗原、CA 125、神经元特异性烯醇化酶及鳞状细胞抗原水平测定在胸腔积液患者血清和胸液中的诊断效用
Cancer. 1999 Oct 15;86(8):1488-95. doi: 10.1002/(sici)1097-0142(19991015)86:8<1488::aid-cncr15>3.0.co;2-y.
3
Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.血清和胸腔积液癌胚抗原、神经元特异性烯醇化酶及细胞角蛋白19片段在原发性肺癌所致胸腔积液患者中的诊断价值
Chest. 2005 Oct;128(4):2298-303. doi: 10.1378/chest.128.4.2298.
4
[Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].[癌胚抗原、神经元特异性烯醇化酶及鳞状细胞癌抗原在恶性胸腔积液中的诊断价值]
An Med Interna. 1996 Aug;13(8):369-73.
5
Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report.神经元特异性烯醇化酶在伴胸腔积液小细胞肺癌诊断中的应用:一项阴性报告
Eur Respir J. 1988 Aug;1(8):698-700.
6
Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.肺腺癌和恶性间皮瘤所致胸腔积液中的肺表面活性物质蛋白-A和癌胚抗原
Eur Respir J. 1995 Mar;8(3):403-6. doi: 10.1183/09031936.95.08030403.
7
Utility of tumour markers in the diagnosis of neoplastic pleural effusion.肿瘤标志物在肿瘤性胸腔积液诊断中的应用
Clin Chim Acta. 1997 Sep 30;265(2):193-205. doi: 10.1016/s0009-8981(97)00120-4.
8
Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.肿瘤标志物对鉴别伊朗患者恶性和良性胸腔积液的诊断价值。
Pathol Oncol Res. 2005;11(4):236-41. doi: 10.1007/BF02893857. Epub 2005 Dec 31.
9
Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.肿瘤标志物在鉴别肺腺癌相关恶性胸腔积液与结核性胸腔积液中的应用。
Am J Med Sci. 2024 Aug;368(2):136-142. doi: 10.1016/j.amjms.2024.04.001. Epub 2024 Apr 5.
10
[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].[肺癌患者与结核性胸膜炎患者胸腔积液中的肿瘤标志物]
Nihon Kokyuki Gakkai Zasshi. 2002 Feb;40(2):106-12.

引用本文的文献

1
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.胸水与血清中癌胚抗原比值对恶性胸腔积液的诊断价值
Ther Adv Med Oncol. 2019 May 22;11:1758835919850341. doi: 10.1177/1758835919850341. eCollection 2019.
2
Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.神经元特异性烯醇化酶对恶性胸腔积液的诊断是否有用?一项验证研究和荟萃分析的证据。
BMC Cancer. 2017 Aug 30;17(1):590. doi: 10.1186/s12885-017-3572-2.
3
Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions.
神经元特异性烯醇化酶(NSE)和癌抗原15-3(CA 15-3)在胸腔积液诊断中的诊断价值
Asian Pac J Cancer Prev. 2017 Jan 1;18(1):257-261. doi: 10.22034/APJCP.2017.18.1.257.
4
Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.评估胸腔积液中的七种肿瘤标志物以诊断恶性胸腔积液。
Br J Cancer. 1999 Nov;81(6):1059-65. doi: 10.1038/sj.bjc.6690807.
5
Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis.癌胚抗原、组织多肽抗原和神经元特异性烯醇化酶的胸膜水平用于通过判别分析对小细胞肺癌和非小细胞肺癌患者进行分类。
J Cancer Res Clin Oncol. 1996;122(8):499-503. doi: 10.1007/BF01187163.